Open access
Cancer‐Control Outcomes of Japanese Vs. German Metastatic Hormone‐Sensitive Prostate Cancer Patients: A Real‐World Cross‐Country Comparison of Patients Undergoing Combination Therapies
Mike Wenzel
Keiichiro Miyajima
M. Filzmayer
A. S. Merseburger
C. Siech
Benedikt Lauer
F. Chun
Shin Koike
Yoichiro Tohi
T. Yanagisawa
K. Tashiro
Takahiro Kimura
F. Urabe
Philipp Mandel
Medicine
Abstract
Differences in tumor biology, ethnicities, and healthcare structures across populations may contribute to variability in oncologic outcomes. This study compared baseline characteristics and oncologic outcomes of Japanese and German metastatic hormone‐sensitive prostate cancer (mHSPC) patients.